Cipla Limited
CIPLA · National Stock Exchange of India (NSE) · Pharmaceuticals
About the company
Cipla is one of India's oldest and largest pharmaceutical companies, known for manufacturing affordable generic medicines across respiratory, anti-retroviral, cardiology, and other therapeutic areas. The company played a landmark role in making affordable HIV/AIDS medicines available in Africa in the early 2000s. Cipla operates manufacturing facilities in India, South Africa, the US, and other countries.
| Exchange | National Stock Exchange of India (NSE) |
| Ticker | CIPLA |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $12.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (National Stock Exchange of India (NSE)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.